Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study (Q35863219)
Jump to navigation
Jump to search
scientific article published on 2 June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study |
scientific article published on 2 June 2015 |
Statements
1 reference
Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study (English)
1 reference
Mojca Jensterle
1 reference
Vesna Salamun
1 reference
Tomaz Kocjan
1 reference
Eda Vrtacnik Bokal
1 reference
Andrej Janez
1 reference
1 reference
1 reference
Identifiers
1 reference